Dr Smithies advised the CMO's private secretary that a compensation scheme for people with haemophilia infected with HIV would need to take into account the claims of recipients of HIV infected blood donations and organ transplants, as well as the implications for people with haemophilia to whom non-A non-B Hepatitis had been transmitted, which was about 96-100% of those treated with products made from plasma pools.